Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: health insurance

ACR Affiliate Society Council Spotlights State Efforts for Advocacy

Christopher D. Adams, MD, FACP, FACR, and Joseph Cantrell, JD  |  June 19, 2019

So far it has been a busy year for the Affiliate Society Council (ASC). Forty-three states are now affiliated with the ACR through the ASC, and we may add another next year. Also, many state legislative sessions have wrapped up, so it’s a great time to provide an overview of the successes—and some of the…

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Affiliate Society Council (ASC)biosimilar legislationbiosimilar substitutionsMedical Association of the State of Alabama (MASA)pharmacy benefit managers (PBMs)state loan forgiveness billstep therapy legislation

ACR Pushes for Increased DXA Reimbursement

Linda Childers  |  June 19, 2019

Broken hips are among the most serious injuries incurred by older adults, and many fractures are preventable. According to the Centers for Disease Control and Prevention (CDC), approximately 300,000 people over the age of 65 are hospitalized each year for hip fractures, with women (who have lower bone density than men) experiencing three-quarters of all…

Filed under:Legislation & Advocacy Tagged with:Dr. Chris Phillipsdual-energy X-ray absorptiometry (DXA)DXA reimbursement cutsFractureship fractureIncreasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (S. 283)Ken Saag

Coding Corner Answers: An Audit Record Request Quiz

From the College  |  June 17, 2019

Take the challenge. C—When an insurance carrier requests the medical record for a service performed, the practice should send all pertinent information to support the medical necessity of that service. For example, if the drug requires that a patient first be tested for tuberculosis and the patient should be on methotrexate or leflunomide, the note…

Filed under:From the CollegePractice Support Tagged with:Auditsprior authorizations

Coding Corner Questions: An Audit Record Request Quiz

From the College  |  June 17, 2019

A private insurance carrier sends an audit request letter to a rheuma­tology practice to review its infusion medical records for the past 30 dates of service. What information should the practice send to the carrier? Only the infusion notes The complete notes for the requested dates of service only The complete notes for the requested…

Filed under:From the CollegePractice Support Tagged with:Auditsprior authorizations

Advocacy Leads to Legislator Access

Paula Marchetta, MD, MBA  |  June 17, 2019

We have often heard it said that opportunity arises from challenges. Challenge, of course, is really just a polite way of saying problem—and for our patients, problems abound when it comes to obtaining timely and affordable access to the rheumatologic care they need. Access in this context has many meanings: There is access to life-changing…

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:Centers for Medicare & Medicaid Services (CMS)E/M codesRheumPAC

A Bridge Between Patients & Rheumatologists: What Social Workers Want Rheumatologists to Know

Linda Childers  |  June 4, 2019

An integral part of the rheumatology care team, social workers can address specific issues related to a patient’s overall wellbeing. Here are some insights into how rheumatologists can better partner with social workers as part of the interdisciplinary team to ensure better patient outcomes…

Filed under:Practice Support Tagged with:Association of Rheumatology Professionals (ARP)Care Teamhealthcare teammultidisciplinary care teampatient caresocial worker

CMS Rule Reflects ACR’s Advocacy, but More Patient Protections Needed

Kelly Tyrrell  |  May 30, 2019

In August 2018, the Centers for Medicare and Medicaid Services (CMS) announced it would permit Medicare Advantage plans to use step therapy for Part B drugs, with a lookback period of just 108 days.1 On May 16, 2019, however, the CMS issued a final rule that extends the lookback period for Part B therapies to 365…

Filed under:Practice SupportProfessional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)lookback periodMedicare Advantage plansMedicare Part B drugspatient safeguardsstep therapy

British Columbia Will Be First Canadian Province to Switch Patients to Biosimilars

Allison Martell & Allison Lampert  |  May 29, 2019

TORONTO/MONTREAL (Reuters)—The Canadian province of British Columbia said on May 28 that its public drug plan will switch as many as 20,400 patients from three branded biologic drugs to cheap near-copies called biosimilars, saving an estimated C$96.6 million ($71.9 million) over three years. The new policy from the province’s PharmaCare program targets Johnson & Johnson’s…

Filed under:Biologics/DMARDsDrug Updates Tagged with:BiologicsBiologics & BiosimilarsBiosimilarsCanada

Wisconsin Rheumatologist Visits Rheumatology Training Program in Nepal

Kathy Holliman  |  May 18, 2019

A Milwaukee rheumatologist delivered lectures, participated in Grand Rounds and consulted on rheumatology treatment strategies during his visit this winter to the Patan Academy of Health Sciences (PAHS), Nepal. Paul Halverson, MD, affiliated with Froedtert Hospital and the Medical College of Wisconsin, says the several days he spent in Patan, Nepal, adjacent to Kathmandu and…

Filed under:Professional Topics Tagged with:Dr. Paul HalversonNepal

Prevent Osteoporotic Fractures with a Fracture Liaison Service

Micah Yu, MD, Anna Lafian, DO, & Christina Downey, MD  |  May 18, 2019

Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk? Unfortunately, this happens every day with osteoporosis and fractures…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:FracturesOsteoporosisosteoporosis treatmentsosteoporotic fracture rates

  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 116
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences